DYSF and muscular dystrophy: In sum, we developed a toolbox across cell-types and species to translate repair of an important DYSF founder mutation into clinical application and demonstrate the first in vivo rescue of a muscular dystrophy by autologous transplantation of gene-edited primary MuSC.